Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
106M
-
Number of holders
-
78
-
Total 13F shares, excl. options
-
32.5M
-
Shares change
-
+1.92M
-
Total reported value, excl. options
-
$195M
-
Value change
-
+$11.6M
-
Put/Call ratio
-
0
-
Number of buys
-
55
-
Number of sells
-
-22
-
Price
-
$6.01
Significant Holders of CORCEPT THERAPEUTICS INC - Common Stock (CORT) as of Q2 2015
87 filings reported holding CORT - CORCEPT THERAPEUTICS INC - Common Stock as of Q2 2015.
CORCEPT THERAPEUTICS INC - Common Stock (CORT) has 78 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 32.5M shares
of 106M outstanding shares and own 30.68% of the company stock.
Largest 10 shareholders include FEDERATED INVESTORS INC /PA/ (14.2M shares), VANGUARD GROUP INC (2.63M shares), BlackRock Institutional Trust Company, N.A. (2.48M shares), MORGAN STANLEY (1.75M shares), INVESTOR AB (1.75M shares), BlackRock Fund Advisors (1.63M shares), STATE STREET CORP (839K shares), NORTHERN TRUST CORP (601K shares), RENAISSANCE TECHNOLOGIES LLC (502K shares), and GEODE CAPITAL MANAGEMENT, LLC (445K shares).
This table shows the top 78 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.